Skip header and navigation

Refine By

24 records – page 1 of 3.

Adverse events following the administration of hepatitis B vaccines.

https://arctichealth.org/en/permalink/ahliterature223953
Source
Can Commun Dis Rep. 1992 Apr 17;18(7):49-53
Publication Type
Article
Date
Apr-17-1992
Author
A. Bentsi-Enchill
Author Affiliation
University of Ottawa.
Source
Can Commun Dis Rep. 1992 Apr 17;18(7):49-53
Date
Apr-17-1992
Language
English
French
Publication Type
Article
Keywords
Canada
Cross-Sectional Studies
Hepatitis B - prevention & control
Hepatitis B Vaccines - administration & dosage - adverse effects
Humans
Incidence
Product Surveillance, Postmarketing
Risk factors
PubMed ID
1291014 View in PubMed
Less detail

Amniocentesis and women with hepatitis B, hepatitis C, or human immunodeficiency virus.

https://arctichealth.org/en/permalink/ahliterature186740
Source
J Obstet Gynaecol Can. 2003 Feb;25(2):145-48, 149-52
Publication Type
Article
Date
Feb-2003
Author
Gregory Davies
R Douglas Wilson
Valérie Désilets
Gregory J Reid
Dorothy Shaw
Anne Summers
Philip Wyatt
David Young
Source
J Obstet Gynaecol Can. 2003 Feb;25(2):145-48, 149-52
Date
Feb-2003
Language
English
French
Publication Type
Article
Keywords
Amniocentesis - methods
Canada
Female
HIV Infections - prevention & control - transmission
Hepatitis B - prevention & control - transmission
Hepatitis C - prevention & control - transmission
Humans
Infectious Disease Transmission, Vertical
MEDLINE
Pregnancy
Pregnancy Complications, Infectious - virology
Prenatal Diagnosis - methods
Risk factors
Abstract
To review the risk of in utero infection through amniocentesis in women with hepatitis B, hepatitis C, or human immunodeficiency virus (HIV).
Fetal and neonatal morbidity and mortality.
Review articles, meta-analyses, and MEDLINE searches from 1966 to 2002 for English-language articles related to amniocentesis, fetal and neonatal infection, and hepatitis B, hepatitis C, or HIV.
The evidence collected was reviewed by the Genetics Committee of the Society of Obstetricians and Gynaecologists of Canada (SOGC) and quantified using the Evaluation of Evidence guidelines developed by the Canadian Task Force on the Periodic Health Exam.
1. The risk of fetal hepatitis B infection through amniocentesis is low. However, knowledge of the maternal hepatitis B e antigen status is valuable in the counselling of risks associated with amniocentesis. (II-1C) 2. Amniocentesis in women infected with hepatitis C does not appear to significantly increase the risk of vertical transmission, but women should be counselled that very few studies have properly addressed this possibility. (II-2C) 3. In HIV-positive women all noninvasive screening tools should be used prior to considering amniocentesis. (II-2D) 4. For women infected with hepatitis B, hepatitis C, or HIV, the addition of noninvasive methods of prenatal risk screening, such as nuchal translucency, triple screening, and anatomic ultrasound, may help in reducing the age-related risk to a level below the threshold for genetic amniocentesis. (II-2C) 5. For those women infected with hepatitis B, hepatitis C, or HIV who insist on amniocentesis, every effort should be made to avoid inserting the needle through the placenta. (II-1B) VALIDATION: These guidelines have been approved by the SOGC Genetics Committee, SOGC Executive, and SOGC Council.
The Society of Obstetricians and Gynaecologists of Canada.
PubMed ID
12577132 View in PubMed
Less detail

Bloodborne pathogens in the health care setting: risk for transmission.

https://arctichealth.org/en/permalink/ahliterature222528
Source
Can Commun Dis Rep. 1992 Dec 25;18(24):177-84
Publication Type
Article
Date
Dec-25-1992

Canada plans new regulations on hepatitis B.

https://arctichealth.org/en/permalink/ahliterature208203
Source
BMJ. 1997 Jun 7;314(7095):1645
Publication Type
Article
Date
Jun-7-1997

Canada to begin screening immigrants for HIV.

https://arctichealth.org/en/permalink/ahliterature195034
Source
IAPAC Mon. 2001 Feb;7(2):40
Publication Type
Article
Date
Feb-2001
Source
J Can Dent Assoc. 1998 Apr;64(4):240, 308
Publication Type
Article
Date
Apr-1998
Author
J. Hardie
Source
J Can Dent Assoc. 1998 Apr;64(4):240, 308
Date
Apr-1998
Language
English
Publication Type
Article
Keywords
Canada
Evidence-Based Medicine
Hepatitis B - prevention & control - transmission
Humans
Infection Control, Dental - methods
Organizational Policy
Societies, Dental
Space Maintenance - instrumentation
Vaccination - utilization
Notes
Comment On: J Can Dent Assoc. 1997 Nov;63(10):775-99401300
Comment On: J Can Dent Assoc. 1997 Nov;63(10):753, 757-60, 764-69401297
Comment On: J Can Dent Assoc. 1997 Nov;63(10):7289401293
PubMed ID
9594462 View in PubMed
Less detail

CDA opposes proposed HBV recommendations.

https://arctichealth.org/en/permalink/ahliterature207117
Source
J Can Dent Assoc. 1997 Nov;63(10):728
Publication Type
Article
Date
Nov-1997
Source
J Can Dent Assoc. 1997 Nov;63(10):728
Date
Nov-1997
Language
English
Publication Type
Article
Keywords
Canada
Hepatitis B - prevention & control - transmission
Humans
Infectious Disease Transmission, Professional-to-Patient - prevention & control
Societies, Dental
Notes
Comment In: J Can Dent Assoc. 1998 Apr;64(4):240, 3089594462
PubMed ID
9401293 View in PubMed
Less detail

Cost without benefit? The introduction of hepatitis B vaccine in Canada.

https://arctichealth.org/en/permalink/ahliterature241902
Source
Can Med Assoc J. 1983 May 15;128(10):1158-60
Publication Type
Article
Date
May-15-1983
Author
R A Coates
J G Rankin
Source
Can Med Assoc J. 1983 May 15;128(10):1158-60
Date
May-15-1983
Language
English
Publication Type
Article
Keywords
Adolescent
Adult
Aged
Canada
Child
Child, Preschool
Cost-Benefit Analysis
Female
Hepatitis B - prevention & control
Hepatitis B virus - immunology
Humans
Infant
Male
Middle Aged
Risk
Viral Vaccines - supply & distribution - therapeutic use
Notes
Cites: Am J Public Health. 1979 Jun;69(6):581-4443498
Cites: Am J Epidemiol. 1979 Sep;110(3):227-36224696
Cites: J Med Virol. 1979;4(4):327-40541683
Cites: Gastroenterology. 1980 Dec;79(6):1159-646777232
Cites: Am J Med. 1981 Feb;70(2):439-447468625
Cites: J Clin Pathol. 1981 Sep;34(9):1017-97276216
Cites: Am J Epidemiol. 1982 Jan;115(1):26-397055128
Cites: Arch Intern Med. 1982 Mar;142(3):481-46802093
Cites: Ann Intern Med. 1982 Jun;96(6 Pt 1):777-97091942
Cites: N Engl J Med. 1982 Sep 9;307(11):644-526810170
Cites: Ann Intern Med. 1982 Sep;97(3):362-66810736
Cites: N Engl J Med. 1973 Nov 29;289(22):1162-64754964
Cites: JAMA. 1974 Feb 25;227(8):901-64405860
Cites: Am J Epidemiol. 1975 Jan;101(1):59-641119482
Cites: Am J Epidemiol. 1975 Sep;102(3):241-501174290
Cites: Ann Intern Med. 1975 Oct;83(4):489-951166979
Cites: JAMA. 1975 Dec 15;234(11):1135-8810605
Cites: Can Med Assoc J. 1975 Nov 22;113(10):945-81104126
Cites: Dev Biol Stand. 1975;30:257-691204962
Cites: J Infect Dis. 1976 Jun;133(6):705-6932496
Cites: Transfusion. 1976 May-Jun;16(3):237-41936273
Cites: Am J Med Sci. 1975 Sep-Oct;270(2):287-911235469
Cites: Transfusion. 1977 Sep-Oct;17(5):490-4910267
Cites: JAMA. 1978 Jan 16;239(3):210-12579391
Cites: J Infect Dis. 1978 Apr;137(4):505-6649994
Cites: Pediatrics. 1978 May;61(5):711-5662509
Cites: Acta Hepatogastroenterol (Stuttg). 1978 Dec;25(6):423-30214987
Cites: Am J Gastroenterol. 1979 Feb;71(2):164-7433898
Cites: Gastroenterology. 1979 Jun;76(6):1319-25437428
PubMed ID
6404544 View in PubMed
Less detail

Evaluation of the effectiveness of immunization delivery methods.

https://arctichealth.org/en/permalink/ahliterature217823
Source
Can J Public Health. 1994 Jul-Aug;85 Suppl 1:S14-30
Publication Type
Article
Author
T W Gyorkos
T N Tannenbaum
M. Abrahamowicz
L. Bédard
J. Carsley
E D Franco
G. Delage
M A Miller
D L Lamping
S A Grover
Author Affiliation
Division of Clinical Epidemiology, Montreal General Hospital, Montreal, Quebec.
Source
Can J Public Health. 1994 Jul-Aug;85 Suppl 1:S14-30
Language
English
Publication Type
Article
Keywords
Adolescent
Adult
Aged
Canada
Child
Child, Preschool
Diphtheria-Tetanus-Pertussis Vaccine
Female
Hepatitis B - prevention & control
Humans
Immunization Programs - standards
Infant
Influenza, Human - prevention & control
Male
Measles - prevention & control
Middle Aged
Mumps - prevention & control
Pneumococcal Infections - prevention & control
Program Evaluation
Rubella - prevention & control
Abstract
Scientific evidence documenting the effectiveness of immunization delivery methods was summarized using the generic approach developed by the Community Health Practice Guidelines Working Group. The delivery methods examined were those for the adult and childhood vaccines of influenza, pneumococcal infection, hepatitis B, measles-mumps-rubella and diphtheria-pertussis-tetanus-polio. Based on a critical appraisal of 54 eligible comparative studies, the effects of different interventions were obtained and pooled effects were calculated for delivery methods oriented to the client, the provider and the system. The results indicate those interventions found to be most effective for each vaccine. This review of the scientific evidence of the effectiveness of immunization delivery methods provides a base for policy development and assists in the planning of resource allocation.
PubMed ID
7987755 View in PubMed
Less detail
Source
CMAJ. 1997 Apr 1;156(7):1033-4
Publication Type
Article
Date
Apr-1-1997
Author
M L Tepper
P R Gully
Author Affiliation
Division of Blood-borne Pathogens, Laboratory Centre for Disease Control, Ottawa, Ont.
Source
CMAJ. 1997 Apr 1;156(7):1033-4
Date
Apr-1-1997
Language
English
French
Publication Type
Article
Keywords
Canada
Hepatitis B - prevention & control
Hepatitis B Vaccines - immunology
Humans
Risk factors
PubMed ID
9099174 View in PubMed
Less detail

24 records – page 1 of 3.